Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1

Author:        

Publisher: Spandidos Publications

E-ISSN: 1791-2431|34|2|884-890

ISSN: 1021-335X

Source: Oncology Reports, Vol.34, Iss.2, 2015-01, pp. : 884-890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content